Antioxidant Effects of Diarylheptanoid Derivatives from Alnus japonica on Human LDL Oxidation

Abstract

Two diarylheptanoids, oregonin (1) and hirsutanone (2), were isolated by bioassay-guided fractionation of the methanol extracts of the leaves of Alnus japonica Steud and their structures were elucidated from their spectroscopic data. Compounds 1 and 2 exhibited significant low-density lipoprotein (LDL)-antioxidant activities, e. g., thiobarbituric acid-reactive substances (TBARS) assay (1: IC₅₀ = 3.2 μM, 2: IC₅₀ = 1.5 μM), lag time (1 : 162 min, 2 : 230 min at 2.0 μM, control: 63 min), relative electrophoretic mobility (REM, inhibition of 1 : 71 %, 2 : 75 % at 10 μM), apoB-100 fragmentation (inhibition of 1 : 27.3 %, 2 : 40.3 % at 10 μM) and macrophage-mediated LDL oxidation (inhibition of 1 : 82 %, 2 : 84 % at 1 μM).

Alnus japonica - Betulaceae - low-density lipoprotein (LDL) - oregonin - hirsutanone

References

• 1 Glass C K, Witzum J L. Atherosclerosis: the road ahead.  Cell. 2001;  104 503-16
• 2 Liao L, Starzyk R M, Granger D N. Molecular determinants of oxidized low-density lipoprotein-induced leukocyte adhesion and microvascular dysfunction.  Arterioscler Thromb Vasc Biol. 1997;  17 437-44
• 3 Dejager S, Mietus-Synder M, Pitas R E. Oxidized low-density lipoproteins bind to the scavenger receptor expressed by rabbit smooth muscle cells and macrophages.  Arterioscler Thromb. 1993;  13 371-8
• 4 Parthasarathy S, Santanam N, Ramachandran S, Meilhac O. Oxidants and antioxidants in atherogenesis: an appraisal.  J Lipid Res. 1999;  40 2143-57
• 5 Lee S J. Korea Folk Medicine. Seoul. Seoul National University Publishing Center Press 1996: p 40
• 6 Lee M W, Kim J H, Jeong D W, Ahn K H, Toh S H, Surh Y J. Inhibition of cyclooxygenase-2 expression by diarylheptanoids from the bark of Alnus hirsuta var. sibirica .  Biol Pharm Bull. 2000;  23 517-8
• 7 Lee M W, Kim N Y, Park M S, Ahn K H, Toh S H, Hahn D R. et al . Diarylheptanoids with in vitro inducible nitric oxide synthesis inhibitory activity from Alnus hirsuta .  Planta Medica. 2000;  66 551-3
• 8 Keseru G M, Nogradi M. In: Studies in Natural Products Chemistry. Atta-ur-Rahman, Ed Elsevier Science New York; 1995 Vol 17: pp 357-68
• 9 Joo S S, Kim H J, Kwon H S, Lee D I. Augmentation of macrophage antitumor activities and nitric oxide production by oregonin.  Arch Pharm Res. 2002;  25 457-62
• 10 Ahn B T, Lee S K, Lee S B, Lee E S, Kim J G, Bok S H. et al . Low-density lipoprotein-antioxidant constituents of Saururus chinensis .  J Nat Prod. 2001;  64 1562-4
• 11 Ohta S, Aoki T, Hirata T, Suga T J. The structures of four diarylheptanoid glycosides from the female flowers of Alnus serrulatoides . J Chem Soc Perkin Trans 1 1984: 1635-42
• 12 Karchesy J J, Laver M L, Barofsky D F, Barofsky E. Structure of oregonin, a natural diarylheptanoid xyloside. J Chem Soc Chem Commun 1974: 649-50
• 13 Lee M W, Tanaka T, Nonaka G I, Nishioka I. Hirsunin, an ellagitannin with a diarylheptanoid moiety, from Alnus hirsuta var. microphylla .  Phytochemistry. 1992;  31 967-70
• 14 Chapman M J, Goldstein S, Lagrange D, Laplaud P M. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum.  J Lid Res. 1981;  22 339-58
• 15 Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein.  Free Radic Res Commun. 1989;  6 67-75
• 16 Jeong T S, Kim K S, Kim J R, Cho K H, Lee S, Lee W S. Novel 3,5-diarylpyrazolines and pyrazole as low-density lipoprotein oxidation inhibitor.  Bioorg Med Chem Lett. 2004;  14 2719-23
• 17 Philippe L, Christiane D, Laure P, Martine M, Sabine G, Brudi M. et al . Impact of a combination of a calcium antagonist and a β-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophage and murine J774 cells.  Arterioscler Thromb Vasc Biol. 1997;  17 979-88
• 18 Reid V C, Mitchinson M J. Toxicity of oxidized low-density lipoprotein towards mouse peritoneal macrophages in vitro .  Atherosclerosis. 1993;  98 17-24
• 19 Miura S, Watanabe J, Tomita T, Sano M, Tomita I. The inhibitory effects of tea polyphenols (flavan-3-ol derivatives) on Cu²⁺-mediated oxidative modification of low density lipoprotein.  Biol Pharm Bull. 1994;  17 1567-72
• 20 Khursheed P N, Enrique B, Charles S L. Dilinoleoylphosphatidylcholine protects human low-density lipoproteins against oxidation.  Atherosclerosis. 2000;  152 89-95